Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients. - Wikidata - wikimedia - TriplyDB

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

http://www.wikidata.org/entity/Q34722521

about

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines.A study of genomic instability in early preneoplastic colonic lesions.Is there pseudoprogression in secondary glioblastomas?Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases.Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients.The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?High levels of cellular proliferation predict pseudoprogression in glioblastoma patients Personalized treatment strategies in glioblastoma: MGMT promoter methylation status.Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation.Pseudoprogression after glioma therapy: a comprehensive review.Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation.Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis.Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma.Pseudoprogression as an adverse event of glioblastoma therapy.MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA.MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry.Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.

P2860

Q30491635-5D74FA06-1BCF-4FB6-89AC-E2A847FFE78C Q33917659-09EF0D39-0961-4C9B-8C18-B9DA0451F8D5 Q33925330-DAE8B72B-5A71-4B31-A388-C62979E6A6A8 Q34514570-F053F418-DD10-45F7-A7A7-BF79B718F063 Q35146128-34DE73DC-60CB-4919-B0EE-C2DDEF213DC0 Q35866022-B37B99EE-A7BE-447F-B24B-AEC321972601 Q36091457-9998B360-BA28-4993-B554-C5132FEBF155 Q36306504-D9444446-213B-4D03-AE72-B4C54CD2C1AD Q36310665-5875F1BB-2C61-4513-BD2B-E2B1A23B548F Q36542980-841E02FF-083A-454B-860C-2E764C2232BE Q36645695-B4C1E048-4CDE-4061-8311-CC55121E9475 Q37221207-5A790ADA-338A-4D80-80FB-0882CE586855 Q37321862-EBF12B5E-24E7-427A-8710-6BD970C3262E Q38094809-134712F1-A37B-4EE2-990D-7E65E423A8DF Q39598112-63EB77F2-2F4F-437D-8BA2-DC8962046C67 Q39765594-353A0132-9D23-40F8-AFB5-3502DB88F432 Q41845711-02DA2C7B-CD2C-425C-8BA6-419408140908 Q42364418-7ADCD6F0-0FBF-45AB-AED0-917ADEBEADFE Q43837625-84767FF8-6984-475E-B2AA-EE13C571AF92 Q43953167-CCED1111-04D5-464C-8924-80DE361AE0EB Q45835773-9E917FA1-7D5D-4C9D-A441-0F0C09AA72A9 Q47100546-483A738A-48B1-4627-B2A0-6AF60866BBCD Q47164037-4BCD092B-AC9E-4EE5-B47D-4370022C0AAE Q49012285-505FF3D6-5203-4C75-AA3F-1FE49098A3AB Q53791485-4DC43F55-499A-49B1-9767-452C07D951BD Q54237934-E631594F-A3E0-4609-93A5-47204C6F0CFB

P2860

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

http://www.wikidata.org/entity/Q34722521

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@ast

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@en

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@nl

type

label

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@ast

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@en

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@nl

prefLabel

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@ast

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@en

Usefulness of MS-MLPA for dete ...... sion in glioblastoma patients.

@nl

P1433

Q34722521-475D95E9-2228-41B3-A7B1-61DF57D397B7

P1476

Q34722521-5E7EB0E2-BDF2-4CAF-8DAB-65117A1C2FE4

P2093

Q34722521-139AEBCF-4EAB-4142-B281-8277F2081949

Q34722521-1695F4E4-41C8-404E-B0F1-629378FF0C1F

Q34722521-379D76AB-8E59-4F65-A54D-9F1E0D56DE73

Q34722521-37DA9E00-2DE1-4D80-9DEB-4973B211F16D

Q34722521-39A6A4A6-1BB9-430A-89F7-A1840D2A35CB

Q34722521-554EEEDC-2CF6-453E-93F0-8BBD4A8090FB

Q34722521-6D691E71-550E-48AC-84A3-F0D5530F3C94

Q34722521-B244EAC7-43C5-45AF-A648-A6D85C5A8609

Q34722521-D5687EB1-5F7B-4935-9BA6-42D82FC54B6B

Q34722521-E2B59878-46D6-44E9-947C-379C60927040

P2860

Q34722521-038385A2-534A-4F85-BAD7-05AF686BB770

Q34722521-04DC7FBD-38CE-496B-AC34-BBE7565F6670

Q34722521-0DD231A9-E00A-4786-A211-978A4D480E1C

Q34722521-2276019A-06DA-4B3C-8864-B84C3F53BD5F

Q34722521-23C2AB7F-9346-403D-96A1-C01EC12E7DAB

Q34722521-30DCEF62-3EC8-4DAA-8C2C-BAEBFE9712DC

Q34722521-65B134FA-9F08-4D56-A26B-13B6107A2C51

Q34722521-6E6ABC1F-C56D-4665-BC15-B153BBE19385

Q34722521-7D64A76A-4A33-4E81-AE54-8759D7776E5E

Q34722521-86043A86-86DA-4FA9-8F4A-905F789DE632

P304

Q34722521-4ABDA0E2-5BD7-4985-984D-688826D6C614

P31

Q34722521-16167E65-8721-49F5-B687-09CF95ECAC7F

P356

Q34722521-0E7F6F88-6E7A-41C7-8918-44C2F45AD8A7

P433

Q34722521-10E59C0C-8D2B-4B33-AE3D-F8BA16918445

P478

Q34722521-4817A8B8-D9CE-4755-B413-ED3CFEB2999C

P50

Q34722521-22EF5FC1-93C9-4C6F-9740-5FC50D5689EE

P577

Q34722521-737F4DF6-0662-4EDC-8A23-06B9518DB810

P5875

Q34722521-4528B466-1D82-4E25-A218-A741CD224E29

P698

Q34722521-0BD80FD5-A21C-4173-9175-5BA112886C05

P921

Q34722521-0A243EB7-AD82-4965-ABAC-5E307D4E5641

P932

Q34722521-63F05D34-A934-468C-8308-58F5EE78F1D7

P356

P1433

P1476

Usefulness of MS-MLPA for dete ...... ssion in glioblastoma patients

@en

P2093

Ah Reum Lee

http://www.w3.org/2001/XMLSchema#string

Chae-Yong Kim

http://www.w3.org/2001/XMLSchema#string

Chul-Kee Park

http://www.w3.org/2001/XMLSchema#string

Dong Gyu Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Won Jung

http://www.w3.org/2001/XMLSchema#string

JinWook Kim

http://www.w3.org/2001/XMLSchema#string

Jung Ho Han

http://www.w3.org/2001/XMLSchema#string

Se-Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Seung-Ki Kim

http://www.w3.org/2001/XMLSchema#string

Su Youn Yim

http://www.w3.org/2001/XMLSchema#string

P2860

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging.

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

New advances that enable identification of glioblastoma recurrence.

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.

P304

195-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ162

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Seung Hong Choi

P577

2010-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47791209

http://www.w3.org/2001/XMLSchema#string

P698

21075779

http://www.w3.org/2001/XMLSchema#string

P921

P932

3064622

http://www.w3.org/2001/XMLSchema#string